Navigation Links
Institute for Neurodegenerative Disorders Deploys OpenClinica EDC solution for Large Parkinson's Study
Date:3/12/2009

OpenClinica has been deployed as the electronic data capture and clinical data management system for a Parkinson's study that could involve up to 15,000 patients.

New Haven, CT (PRWEB) March 12, 2009 -- The Institutive for Neurodegenerative Disorders (IND) announces that has deployed the OpenClinica clinical data capture and management software for the Parkinson's Associated Risk Study (PARS).

PARS is a clinical study to develop a pre-motor Parkinson disease (PD) cohort using a combination of olfactory testing and dopamine transporter imaging to detect those at risk for PD. This ambitious project will recruit up to 15,000 study subjects from throughout the US who will participate in predictive testing. For more information about the PARS study, see http://www.parsinfosource.com/index.htm.

IND has selected OpenClinica to streamline clinical data collection and management for this clinical trial. Through the OpenClinica Enterprise program, the PARS study will receive a certified implementation of OpenClinica electronic data capture system, customization of certain features, training for users, and ongoing support for the popular open source eClinical software.

"We are excited about the progress of the PARS study and our collaboration with OpenClinica in this and other research studies sponsored by the Institute," said Dr. Danna Jennings, Clinical Research Director at IND. "In the PARS study, data management is a crucial component of success and OpenClinica has provided a flexible and versatile platform that will ensure the quality and consistency of the PARS data."

Through OpenClinica Enterprise, an organization conducting clinical research can obtain a spectrum of services to enhance their use of the OpenClinica software. OpenClinica Enterprise enables a research institution to maintain its independence from software vendors while obtaining full support for a modern, robust clinical research software technology.

About the Institute for Neurodegenerative Disorders
The Institute for Neurodegenerative Disorders (IND) is an independent not-for-profit research institute located in New Haven, Connecticut. The mission of IND is to develop improved treatments, diagnostic tools and educational programs for neurologic disorders such as Parkinson disease, Huntington disease and Alzheimer disease through clinical research.

IND specializes in clinical and neuroimaging research and is developing tools to diagnose neurologic disorders at the earliest possible stages of disease. IND also conducts large multi-center studies aimed at understanding medications that may influence the influence the disease's rate of progression. For more information see http://www.indd.org.

About OpenClinica®
OpenClinica is open source web-based electronic data capture software for clinical research. It facilitates protocol configuration, design of case report forms, clinical data capture, and study/data management. OpenClinica supports HIPAA, GCP, and 21 CFR Part 11 guidelines and is designed as a lightweight, standards-based, extensible, and modular platform. OpenClinica is available for download at http://www.openclinica.org.

About Akaza Research®
Akaza Research, the leading provider of open source clinical trial software, is headquartered in Cambridge, Massachusetts. Supported by the National Institutes of Health (NIH) and dozens of other leading research institutions, Akaza has developed and commercialized OpenClinica, the preeminent open source clinical trial data capture and management software platform. Akaza brings Open Source Software (OSS) into the mainstream of the clinical research enterprise by making robust, flexible, standards-based systems accessible for private and public research. Akaza Research provides OpenClinica support, training, and consulting services to its customers worldwide. See http://www.akazaresearch.com.

###

Read the full story at http://www.prweb.com/releases/clinical_trials_software/electronic_data_capture/prweb2223244.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Netherlands Vaccine Institute Chooses TrackWise(R) Solution for Enterprise-wide Compliance with Good Manufacturing Practices
2. Ventura County Star Newspaper Honors Khanna Institute
3. BancTec Provides Thought Leadership at 7th Annual Medical Banking Institute
4. The REACH Institute: Best Practice Guidelines Address Mental Health Needs of Youth in Care
5. Aspen Institute to Introduce Roadmap for Responsible Health Care Reform, New Coalition To Call For Sustainable Improvements
6. Karmanos Cancer Institute Announces Interim Leadership
7. SXC Health Solutions Awarded The Pharmacy Benefit Management Institutes 2009 Innovation Award
8. The Texas Institute of Dermatology Team Finds Easy-to-Apply, Topical Drug Just as Good as Injectable Compound for a Disfigurating Skin Infection
9. Johnson Institute Transfers Key Programs and Products to Hazelden Foundation
10. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center First in Nation to Use NaviStar(R) RMT ThermoCool(R) Catheter Since Technology Received FDA Approval
11. Cambridge Healthtech Institute Announces Its Premiere Collaborative Innovation in Biomedicine Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Institute for Neurodegenerative Disorders Deploys OpenClinica EDC solution for Large Parkinson's Study
(Date:2/26/2017)... , ... February 26, 2017 , ... ... for entries to the 7th Edition of International Social Design Awards. , ... Professionals, Product Designers, System Designers, Governments and Institutions worldwide with realized projects and ...
(Date:2/26/2017)... , ... February 26, 2017 , ... ... wholesale distribution in North America, today announced it would be offering some it’s ... which prides itself on crafting quality and unique baby clothing/feeding products, will team ...
(Date:2/26/2017)... VA (PRWEB) , ... February 26, 2017 , ... ODH, ... Managed Care Summit, February 27-28 at the Sheraton Pentagon City Hotel in Arlington, VA. ... with PerformCARE to use behavioral health analytics to improve Medicaid population health management. , ...
(Date:2/25/2017)... (PRWEB) , ... February 25, 2017 , ... FCPX users ... Color tools from Pixel Film Studios. With ProSharpen Color users have total control over ... easily refine their color range. With color spectrum tools users can visually see the ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the official release of ... in Cannes (France), XO Private has initiated a second print-run of its lavish luxury ... a metre across when open, weighs in at more than six kilos, retails at ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Feb. 23, 2017 Non-alcoholic ... on the various drugs being developed for ... all the drugs that are in various ... The pipeline focuses on novel pharmacologic drugs ... stem cell therapies, recombinant proteins and RNA-based ...
(Date:2/24/2017)... Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology ... it has acquired exclusive worldwide rights to develop, ... HDAC inhibitor targeting hematological and solid tumors. ... 1 and 2 clinical trials of Abexinostat in ... have already been completed, demonstrating that Abexinostat is ...
(Date:2/23/2017)... Research and Markets has announced the addition of the "Autism ... to their offering. ... The latest research Autism Spectrum Disorder Drugs Price Analysis and ... global Autism Spectrum Disorder market. The research answers the following ... marketed for Autism Spectrum Disorder and their clinical attributes? How are ...
Breaking Medicine Technology: